DOCSLIB.ORG

Synthesis and Characterization of Functionalized

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Synthesis and Characterization of Functionalized SYNTHESIS AND CHARACTERIZATION OF FUNCTIONALIZED RECOMBINANT THROMBOMODULIN FOR ANTITHROMBOTIC DRUG DEVELOPMENT LIN WANG Bachelor of Pharmaceutical Science Shenyang Pharmaceutical University, China July 2009 Submitted in partial fulfillment of requirements for the degree of DOCTOR OF PHILOSOPHY IN CLINICAL-BIOANALYTICAL CHEMISTRY at the CLEVELAND STATE UNIVERSITY AUGUST 2015 We hereby approve this dissertation for Lin Wang Candidate for the Doctor of Philosophy in Clinical-Bioanalytical Chemistry Degree for the Department of Chemistry and CLEVELAND STATE UNIVERSITY College of Graduate Studies _____________________________________________________________ Dissertation Chairperson, Xue-Long Sun, Ph.D. _____________________________________ Department & Date ______________________________________________________________ Anthony Berdis, Ph.D. ______________________________________ Department & Date _______________________________________________________________ Baochuan Guo, Ph.D. ________________________________________ Department & Date ______________________________________________________________ Nolan Holland, Ph.D. ______________________________________ Department & Date ________________________________________________________________ Sihe Wang, Ph.D. ___________________________________________ Department & Date _________________________________________________________________ Aimin Zhou, Ph.D. _____________________________________________ Department & Date Date of Defense: August 4th 2015 ACKNOWLEDGEMENTS I owe my gratitude to all those people who have helped me to make this dissertation. I am grateful for their time and efforts which have contributed to my professional growth and education throughout my years as a graduate student. First and foremost, I would like to give my deepest gratitude to my advisor, Dr. Xue- Long Sun for providing me the opportunity to work with him and for his persistent support and guidance throughout my PhD process. His enduring enthusiasm and rigorousness in scientific research will always inspire me throughout my life careers. Without his guidance and persistent help this dissertation would not have been possible. Next, I would like to thank my committee members, Dr. Anthony Berdis, Dr. Baochuan Guo, Dr. Nolan Holland, Dr. Sihe Wang and Dr. Aimin Zhou, for their insightful comments and suggestions and valuable support for my projects. I would also like to thank all past and current members in Dr. Sun lab for all their assistance and suggestions for my experiments. Particularly, I would like to thank Dr. Jiang for giving me the guidance and training in chemical biology. Last but not the least, I would like to give my sincere acknowledgement to my family members. Their continuous encouragement, support and love are always the driving forces for me to work hard. SYNTHESIS AND CHARACTERIZATION OF FUNCTIONALIZED RECOMBINANT THROMBOMODULIN FOR ANTITHROMBOTIC DRUG DEVELOPMENT LIN WANG ABSTRACT Thrombomodulin (TM), an endothelial cell surface membrane glycoprotein, is a cofactor for protein C activation via thrombin, and therefore a crucial regulator in protein C pathway and coagulation cascade. TM contains six epidermal growth factor (EGF)–like structures, in which the forth to sixth EGF-like region (TM456) is the minimum functional domain responsible for protein C activation activity and could serve as a pure anticoagulant agent. However, recombinant TM456 has a short half-life (6-9 min) that limits its therapeutic application. Modification with polymer such as PEG should be a choice to enhance the pharmacokinetics of recombinant TM456. In addition, incorporation of protein into liposome provides several benefits including prolonged half-life and targeted drug delivery as well. Therefore, this study aimed to develop TM456 conjugates as novel and potential antithrombotic drugs. Site-specific modification of protein is the key for protein conjugate preparation for either defined conjugate formation or unchanged protein activity. Firstly, a one-pot strategy for site-specific PEGylation through copper-free click chemistry (CFCC) and fluorescent labeling through sortase-mediated ligation (SML) of recombinant TM without prior chemical modification and without diminishing the protein activity has been iv developed. Modification with polymer PEG aims enhances the pharmacokinetics of recombinant TM456. In addition, incorporation of a tag to the recombinant TM456 for subsequent detection or affinity purification facilitates efficient biological evaluation for both in vitro and in vivo experiments. Secondly, in order to obtain the azide bearing TM456 for further protein modification via CFCC, four site-selective strategies to introduce azide functionality into TM456, via direct recombinant expression with unnatural amino acid, chemical, and enzymatic modification were fully investigated. Among them, SML of recombinant protein affords the highest overall yield for incorporating azide functionality into recombinant TM456 and retained the full TM anticoagulant activity as well. Finally, synthesis and characterization of liposome-TM456 conjugates were investigated by synthesizing the DSPE-PEG2000-TM456 from azido-TM456 and DSPE- PEG2000-DBCO via CFCC followed by direct liposome formation method. This liposomal formulation of TM456 retained the same protein C activation activity as the unmodified TM456, and turned out to be much more stable in plasma than azido-TM456. Further, liposome-TM456 showed a comparable anticoagulant effect in thrombin-induced thromboembolism mouse model by reducing the mortality from 80% to 20%. Moreover, liposome-TM456 enhanced the circulation time than free azido-TM456 in vivo. v TABLE OF CONTENTS ABSTRACT ....................................................................................................................... iv LIST OF TABLES ............................................................................................................. xi LIST OF FIGURES .......................................................................................................... xii ABBREVIATIONS ......................................................................................................... xiv CHAPTER I. INTRODUCTION ........................................................................................................... 1 1.1 Thrombomodulin and its antithrombotic activities ................................................... 1 1.1.1 Structure of TM .................................................................................................. 2 1.1.2 Biological functions of TM ................................................................................ 5 1.1.3 Therapeutic application of recombinant TM ...................................................... 8 1.2 Bioconjugation strategies for protein functionalization .......................................... 11 1.2.1 Click chemistry ................................................................................................. 15 1.2.2 Sortase-mediated ligation ................................................................................. 17 1.3 Liposomes as drug delivery systems ....................................................................... 19 1.3.1 Conventional liposomes ............................................................................................20 1.3.2 Stealth liposomes .............................................................................................. 22 1.3.3 Targeted liposomes ........................................................................................... 23 1.3.4 Preparation methods of liposomes with ligand................................................. 26 1.3.4.1 Direct liposome formation with ligands .................................................... 26 1.3.4.2 Post-insertion approach .............................................................................. 26 vi 1.3.4.3 Post-functionalization approach ................................................................. 27 1.4 Research Design and Rational................................................................................. 28 1.5 References ............................................................................................................... 29 II. CHEMOENZYMATIC BIO-ORTHOGONAL CHEMISTRY FOR SITE-SPECIFIC DOUBLE MODIFICATION OF RECOMBINANT TM456AL ....................................... 47 2.1 Introduction ............................................................................................................. 47 2.2 Results and discussion ............................................................................................. 50 2.2.1 Expression and purification of TM456AL ......................................................... 50 2.2.2 Double-labeling of TM2 with DIBO-AF647 or/and Gly2-Bodipy ................... 51 2.2.3 Optimization of one-pot double-modification reaction conditions ................. 52 2.2.4 One-pot PEGylation and fluorescent labeling of TM456AL ............................. 56 2.2.5 PEGylation of TM456AL via sortase-mediated ligation with Gly2-PEG5000-OMe ................................................................................................................................... 58 2.2.6 Protein C activation activity of TM456AL and TM456AL conjugates ............... 61 2.3 Conclusion ............................................................................................................... 63 2.4 Materials and methods ...........................................................................................
Load more

Recommended publications
  • Subtiligase-Catalyzed Peptide Ligation Amy M
    Review Cite This: Chem. Rev. 2020, 120, 3127−3160 pubs.acs.org/CR Subtiligase-Catalyzed Peptide Ligation Amy M. Weeks*,† and James A. Wells*,†,‡ † Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, California 94143, United States ‡ Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, California 94143, United States ABSTRACT: Subtiligase-catalyzed peptide ligation is a powerful approach for site- specific protein bioconjugation, synthesis and semisynthesis of proteins and peptides, and chemoproteomic analysis of cellular N termini. Here, we provide a comprehensive review of the subtiligase technology, including its development, applications, and impacts on protein science. We highlight key advantages and limitations of the tool and compare it to other peptide ligase enzymes. Finally, we provide a perspective on future applications and challenges and how they may be addressed. CONTENTS 6.1. Subtiligase-Catalyzed Thioester and Thioa- cid Synthesis for Peptide and Protein 1. Introduction 3128 Bioconjugation 3138 2. Using Proteases in Reverse for Peptide Bond 6.2. Peptide Segment Condensation 3139 Formation 3129 6.3. Peptide Cyclization 3140 2.1. Protease-Catalyzed Peptide Bond Synthesis 6.4. Total Protein Synthesis 3140 under Thermodynamic Control 3129 7. Application of Subtiligase for Site-Specific 2.2. Protease-Catalyzed Peptide Bond Synthesis Protein Bioconjugation 3141 under Kinetic Control 3129 7.1. Sequence and Structural Requirements for 3. Protein Engineering of Subtilisin for Improved N-Terminal Modification by Subtiligase 3142 Peptide Bond Synthesis 3129 7.1.1. Characterization of Sequence and 3.1. Mutation of the Catalytic Serine to Cysteine 3129 Structural Requirements 3142 3.2.
    [Show full text]
  • Cysteine Proteinases of Microorganisms and Viruses
    ISSN 00062979, Biochemistry (Moscow), 2008, Vol. 73, No. 1, pp. 113. © Pleiades Publishing, Ltd., 2008. Original Russian Text © G. N. Rudenskaya, D. V. Pupov, 2008, published in Biokhimiya, 2008, Vol. 73, No. 1, pp. 317. REVIEW Cysteine Proteinases of Microorganisms and Viruses G. N. Rudenskaya1* and D. V. Pupov2 1Faculty of Chemistry and 2Faculty of Biology, Lomonosov Moscow State University, 119991 Moscow, Russia; fax: (495) 9393181; Email: [email protected] Received May 7, 2007 Revision received July 18, 2007 Abstract—This review considers properties of secreted cysteine proteinases of protozoa, bacteria, and viruses and presents information on the contemporary taxonomy of cysteine proteinases. Literature data on the structure and physicochemical and enzymatic properties of these enzymes are reviewed. High interest in cysteine proteinases is explained by the discovery of these enzymes mostly in pathogenic organisms. The role of the proteinases in pathogenesis of several severe diseases of human and animals is discussed. DOI: 10.1134/S000629790801001X Key words: cysteine proteinases, properties, protozoa, bacteria, viruses Classification and Catalytic Mechanism papain and related peptidases showed that the catalytic of Cysteine Proteinases residues are arranged in the following order in the polypeptide chain: Cys, His, and Asn. Also, a glutamine Cysteine proteinases are peptidyl hydrolases in residue preceding the catalytic cysteine is also important which the role of the nucleophilic group of the active site for catalysis. This residue is probably involved in the for is performed by the sulfhydryl group of a cysteine residue. mation of the oxyanion cavity of the enzyme. The cat Cysteine proteinases were first discovered and investigat alytic cysteine residue is usually followed by a residue of ed in tropic plants.
    [Show full text]
  • Serine Proteases with Altered Sensitivity to Activity-Modulating
    (19) & (11) EP 2 045 321 A2 (12) EUROPEAN PATENT APPLICATION (43) Date of publication: (51) Int Cl.: 08.04.2009 Bulletin 2009/15 C12N 9/00 (2006.01) C12N 15/00 (2006.01) C12Q 1/37 (2006.01) (21) Application number: 09150549.5 (22) Date of filing: 26.05.2006 (84) Designated Contracting States: • Haupts, Ulrich AT BE BG CH CY CZ DE DK EE ES FI FR GB GR 51519 Odenthal (DE) HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI • Coco, Wayne SK TR 50737 Köln (DE) •Tebbe, Jan (30) Priority: 27.05.2005 EP 05104543 50733 Köln (DE) • Votsmeier, Christian (62) Document number(s) of the earlier application(s) in 50259 Pulheim (DE) accordance with Art. 76 EPC: • Scheidig, Andreas 06763303.2 / 1 883 696 50823 Köln (DE) (71) Applicant: Direvo Biotech AG (74) Representative: von Kreisler Selting Werner 50829 Köln (DE) Patentanwälte P.O. Box 10 22 41 (72) Inventors: 50462 Köln (DE) • Koltermann, André 82057 Icking (DE) Remarks: • Kettling, Ulrich This application was filed on 14-01-2009 as a 81477 München (DE) divisional application to the application mentioned under INID code 62. (54) Serine proteases with altered sensitivity to activity-modulating substances (57) The present invention provides variants of ser- screening of the library in the presence of one or several ine proteases of the S1 class with altered sensitivity to activity-modulating substances, selection of variants with one or more activity-modulating substances. A method altered sensitivity to one or several activity-modulating for the generation of such proteases is disclosed, com- substances and isolation of those polynucleotide se- prising the provision of a protease library encoding poly- quences that encode for the selected variants.
    [Show full text]
  • Proteolytic Enzymes in Grass Pollen and Their Relationship to Allergenic Proteins
    Proteolytic Enzymes in Grass Pollen and their Relationship to Allergenic Proteins By Rohit G. Saldanha A thesis submitted in fulfilment of the requirements for the degree of Masters by Research Faculty of Medicine The University of New South Wales March 2005 TABLE OF CONTENTS TABLE OF CONTENTS 1 LIST OF FIGURES 6 LIST OF TABLES 8 LIST OF TABLES 8 ABBREVIATIONS 8 ACKNOWLEDGEMENTS 11 PUBLISHED WORK FROM THIS THESIS 12 ABSTRACT 13 1. ASTHMA AND SENSITISATION IN ALLERGIC DISEASES 14 1.1 Defining Asthma and its Clinical Presentation 14 1.2 Inflammatory Responses in Asthma 15 1.2.1 The Early Phase Response 15 1.2.2 The Late Phase Reaction 16 1.3 Effects of Airway Inflammation 16 1.3.1 Respiratory Epithelium 16 1.3.2 Airway Remodelling 17 1.4 Classification of Asthma 18 1.4.1 Extrinsic Asthma 19 1.4.2 Intrinsic Asthma 19 1.5 Prevalence of Asthma 20 1.6 Immunological Sensitisation 22 1.7 Antigen Presentation and development of T cell Responses. 22 1.8 Factors Influencing T cell Activation Responses 25 1.8.1 Co-Stimulatory Interactions 25 1.8.2 Cognate Cellular Interactions 26 1.8.3 Soluble Pro-inflammatory Factors 26 1.9 Intracellular Signalling Mechanisms Regulating T cell Differentiation 30 2 POLLEN ALLERGENS AND THEIR RELATIONSHIP TO PROTEOLYTIC ENZYMES 33 1 2.1 The Role of Pollen Allergens in Asthma 33 2.2 Environmental Factors influencing Pollen Exposure 33 2.3 Classification of Pollen Sources 35 2.3.1 Taxonomy of Pollen Sources 35 2.3.2 Cross-Reactivity between different Pollen Allergens 40 2.4 Classification of Pollen Allergens 41 2.4.1
    [Show full text]
  • Recognition of Class II MHC Peptide Ligands That Contain Β-Amino Acids Ross W
    Recognition of Class II MHC Peptide Ligands That Contain β-Amino Acids Ross W. Cheloha, Andrew W. Woodham, Djenet Bousbaine, Tong Wang, Shi Liu, John Sidney, Alessandro Sette, Samuel This information is current as H. Gellman and Hidde L. Ploegh of October 1, 2021. J Immunol published online 7 August 2019 http://www.jimmunol.org/content/early/2019/08/06/jimmun ol.1900536 Downloaded from Supplementary http://www.jimmunol.org/content/suppl/2019/08/06/jimmunol.190053 Material 6.DCSupplemental http://www.jimmunol.org/ Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication *average by guest on October 1, 2021 Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2019 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. Published August 7, 2019, doi:10.4049/jimmunol.1900536 The Journal of Immunology Recognition of Class II MHC Peptide Ligands That Contain b-Amino Acids Ross W. Cheloha,* Andrew W. Woodham,* Djenet Bousbaine,*,† Tong Wang,‡ Shi Liu,‡ John Sidney,x Alessandro Sette,x,{ Samuel H.
    [Show full text]
  • [Thesis Title Goes Here]
    BIOLOGICALLY ACTIVE ASSEMBLIES THAT ATTENUATE THROMBOSIS ON BLOOD-CONTACTING SURFACES A Dissertation Presented to The Academic Faculty by Zheng Qu In Partial Fulfillment of the Requirements for the Degree Doctor of Philosophy in Bioengineering Georgia Institute of Technology December 2012 BIOLOGICALLY ACTIVE ASSEMBLIES THAT ATTENUATE THROMBOSIS ON BLOOD-CONTACTING SURFACES Approved by: Dr. Elliot L. Chaikof, Advisor Dr. Larry V. McIntire The Wallace H. Coulter Department of The Wallace H. Coulter Department of Biomedical Engineering Biomedical Engineering Georgia Institute of Technology Georgia Institute of Technology Department of Surgery Beth Israel Deaconess Medical Center Dr. Julia E. Babensee Dr. W. Robert Taylor The Wallace H.Coulter Department of Division of Cardiology Biomedical Engineering Emory University School of Medicine Georgia Institute of Technology Dr. Stephen R. Hanson Department of Biomedical Engineering Oregon Health and Science University Date Approved: November 2, 2012 Dedicated to my parents, for their unconditional love. ACKNOWLEDGEMENTS The progress and advances made in this research were enabled by contributions from many colleagues and peers, as well as support from family and friends. It is these relationships that were forged during the course of my career that I cherish the most. First and foremost, I want to express my sincerest gratitude for Dr. Elliot Chaikof, for guiding me through the many challenges of scientific research with innovative ideas and patient advice, and above all, by always keeping the “big picture” in perspective. Dr. Chaikof has taken the time to personally support every step along the way of my career as a PhD candidate despite his huge commitments to the clinic.
    [Show full text]
  • Asymmetric Disulfanylbenzamides As Irreversible and Selective Inhibitors
    Full Papers ChemMedChem doi.org/10.1002/cmdc.201900687 1 2 3 Asymmetric Disulfanylbenzamides as Irreversible and 4 5 Selective Inhibitors of Staphylococcus aureus Sortase A 6 [a] [b] [b] [a] 7 Fabian Barthels, Gabriella Marincola, Tessa Marciniak, Matthias Konhäuser, [a] [c] [d, e] [a, f] [d] 8 Stefan Hammerschmidt, Jan Bierlmeier, Ute Distler, Peter R. Wich, Stefan Tenzer, 9 Dirk Schwarzer,[c] Wilma Ziebuhr,[b] and Tanja Schirmeister*[a] 10 11 12 Staphylococcus aureus is one of the most frequent causes of methods allowed the experimentally observed binding affinities 13 nosocomial and community-acquired infections, with drug- and selectivities to be rationalized. The most active compounds 14 resistant strains being responsible for tens of thousands of were found to have single-digit micromolar Ki values and 15 deaths per year. S. aureus sortase A inhibitors are designed to caused up to a 66% reduction of S. aureus fibrinogen attach- 16 interfere with virulence determinants. We have identified ment at an effective inhibitor concentration of 10 μM. This new 17 disulfanylbenzamides as a new class of potent inhibitors against molecule class exhibited minimal cytotoxicity, low bacterial 18 sortase A that act by covalent modification of the active-site growth inhibition and impaired sortase-mediated adherence of 19 cysteine. A broad series of derivatives were synthesized to S. aureus cells. 20 derive structure-activity relationships (SAR). In vitro and in silico 21 22 Introduction target structures.[2] SrtA mediates the attachment of surface 23 proteins to the bacterial cell wall and it was shown that an S. 24 The ongoing spread of antibiotic resistance among Gram- aureus ΔSrtA mutant is clearly attenuated in mouse infection 25 positive bacteria such as Staphylococcus aureus highlights the models compared to the wild type.[3,4] SrtA inhibitors are likely 26 need for new treatment options beyond traditional antibiotics.
    [Show full text]
  • Sorting out Sortases: Designing a Better Enzyme and Synthesizing Trapping Peptides Towards Capturing a Bound-State Structure
    Western Washington University Western CEDAR WWU Honors Program Senior Projects WWU Graduate and Undergraduate Scholarship Spring 2020 Sorting Out Sortases: Designing a Better Enzyme and Synthesizing Trapping Peptides Towards Capturing a Bound-State Structure Katherine Johnston Western Washington University Follow this and additional works at: https://cedar.wwu.edu/wwu_honors Part of the Chemistry Commons Recommended Citation Johnston, Katherine, "Sorting Out Sortases: Designing a Better Enzyme and Synthesizing Trapping Peptides Towards Capturing a Bound-State Structure" (2020). WWU Honors Program Senior Projects. 398. https://cedar.wwu.edu/wwu_honors/398 This Project is brought to you for free and open access by the WWU Graduate and Undergraduate Scholarship at Western CEDAR. It has been accepted for inclusion in WWU Honors Program Senior Projects by an authorized administrator of Western CEDAR. For more information, please contact [email protected]. Sorting Out Sortases: Designing a Better Enzyme and Synthesizing Trapping Peptides Towards Capturing a Bound-State Structure By Katherine Johnston June 2020 A Thesis Presented to The Honors Department of Western Washington University In Partial Fulfillment Of the Requirements for University Honors Abstract Sortase A is a powerful protein engineering tool that cleaves proteins and attaches them to an acyl acceptor of choice. However, the most active wild type variants of sortase A only show high activity at a limited number of cleavage motifs, and so work is underway to create a variant of sortase A that shows high activity at a greater variety of cleavage sites. Additionally, current studies attempting to optimize the enzyme require a way to stabilize an unstructured loop for the crystallization, in order to collect X-ray diffraction structural data.
    [Show full text]
  • Sortase Enzymes and Their Integral Role in the Development of Streptomyces Coelicolor
    Sortase enzymes and their integral role in the development of Streptomyces coelicolor Sortase enzymes and their integral role in the development of Streptomyces coelicolor Andrew Duong A Thesis Submitted to the School of Graduate Studies In Partial Fulfillment of the Requirements of the Degree of Master of Science McMaster University Copyright by Andrew Duong, December, 2014 Master of Science (2014) McMaster University (Biology) Hamilton, Ontario TITLE: Sortase enzymes and their integral role in the development of Streptomyces coelicolor AUTHOR: Andrew Duong, B.Sc. (H) (McMaster University) SUPERVISOR: Dr. Marie A. Elliot NUMBER OF PAGES: VII, 77 Abstract Sortase enzymes are cell wall-associated transpeptidases that facilitate the attachment of proteins to the peptidoglycan. Exclusive to Gram positive bacteria, sortase enzymes contribute to many processes, including virulence and pilus attachment, but their role in Streptomyces coelicolor biology remained elusive. Previous work suggested that the sortases anchored a subset of a group of hydrophobic proteins known as the long chaplins. The chaplins are important in aerial hyphae development, where they are secreted from the cells and coat the emerging aerial hyphae to reduce the surface tension at the air-aqueous interface. Two sortases (SrtE1 and SrtE2) were predicted to anchor these long chaplins to the cell wall of S. coelicolor. Deletion of both sortases or long chaplins revealed that although the long chaplins were dispensable for wild type-like aerial hyphae formation, the sortase mutant had a severe defect in growth. These two sortases were found to be nearly redundant, as deletion of individual enzymes led to only a modest change in phenotype.
    [Show full text]
  • Wo2019/135816
    ( (51) International Patent Classification: GOPADHYAY, Soumyashree Ashok [US/US]; c/o 75 A61K 48/00 (2006.01) Francis Street, Boston, Massachusetts 021 15 (US). (21) International Application Number: (74) Agent: RUTLEDGE, Rachel D. et al.; Johnson, Marcou & PCT/US20 18/057 182 Isaacs, LLC, P. O .Box 691, Floschton, Georgia 30548 (US). (22) International Filing Date: (81) Designated States (unless otherwise indicated, for every 23 October 2018 (23. 10.2018) kind of national protection av ailable) . AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, (25) Filing Language: English CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, (26) Publication Language: English DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, (30) Priority Data: KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, 62/575,948 23 October 2017 (23. 10.2017) US MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, 62/765,347 20 August 2018 (20.08.2018) US OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, (71) Applicants: THE BROAD INSTITUTE, INC. [US/US]; SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, 415 Main Street, Cambridge, Massachusetts 02142 (US). TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. THE BRIGHAM AND WOMEN'S HOSPITAL, INC. (84) Designated States (unless otherwise indicated, for every [US/US]; 75 Francis Street, Boston, Massachusetts 021 15 kind of regional protection available) .
    [Show full text]
  • Enzyme‐Catalysed Polymer Cross‐Linking
    Maddock, R. M. A., Pollard, G. J., Moreau, N. G., Perry, J. J., & Race, P. R. (2020). Enzyme-catalysed polymer cross-linking: Biocatalytic tools for chemical biology, materials science and beyond. Biopolymers, [e23390]. https://doi.org/10.1002/bip.23390 Publisher's PDF, also known as Version of record License (if available): CC BY Link to published version (if available): 10.1002/bip.23390 Link to publication record in Explore Bristol Research PDF-document This is the final published version of the article (version of record). It first appeared online via Wiley at https://onlinelibrary.wiley.com/doi/full/10.1002/bip.23390. Please refer to any applicable terms of use of the publisher. University of Bristol - Explore Bristol Research General rights This document is made available in accordance with publisher policies. Please cite only the published version using the reference above. Full terms of use are available: http://www.bristol.ac.uk/red/research-policy/pure/user-guides/ebr-terms/ Received: 27 April 2020 Revised: 13 June 2020 Accepted: 15 June 2020 DOI: 10.1002/bip.23390 REVIEW Enzyme-catalysed polymer cross-linking: Biocatalytic tools for chemical biology, materials science and beyond Rosie M. A. Maddock1,2 | Gregory J. Pollard1 | Nicolette G. Moreau1 | Justin J. Perry3 | Paul R. Race1,2 1School of Biochemistry, University of Bristol, University Walk, Bristol, UK Abstract 2BrisSynBio Synthetic Biology Research Intermolecular cross-linking is one of the most important techniques that can be used Centre, Life Sciences Building, Tyndall Avenue to fundamentally alter the material properties of a polymer. The introduction of cova- University of Bristol, Bristol, UK 3Department of Applied Sciences, lent bonds between individual polymer chains creates 3D macromolecular assemblies Northumbria University, Ellison Building, with enhanced mechanical properties and greater chemical or thermal tolerances.
    [Show full text]
  • Activated Platelets and Antibody Opsonization As Tumor Markers
    Activated Platelets and Antibody Opsonization as Tumor Markers: Novel Avenues for Cancer Diagnosis, Targeted Therapy and Monitoring Therapeutic Outcomes May Lin Yap Submitted in total fulfilment of the requirements of the degree of Doctor of Philosophy September 2018 Department of Clinical Pathology Faculty of Medicine, Dentistry and Health Sciences The University of Melbourne Declaration This is to certify that I. This thesis comprises only of my original work towards the Doctor of Philosophy degree, except where indicated in the preface; II. Due acknowledgement has been made in the text to all other materials used; III. The thesis is fewer than 100,000 words in length, exclusive of tables, bibliographies and appendices as approved by the Research Higher Degrees Committee. May Lin Yap September 2018 I Acknowledgement To say my journey towards completing this dissertation was one filled with reward and gratification is, truthfully speaking, understating the uplifting sense of self-worth and purpose that I feel as a researcher. What is even more meaningful and of significance to me however is that I did not make this journey alone: I therefore must express my heartfelt gratitude to the people who have contributed to this endeavour. To my PhD supervisors, Mark Hogarth and Karlheinz Peter, thank you for the opportunity to undertake this PhD under both your guidance. It is such a virtuous task to be a supervisor, and I am honored to have had the opportunity to learn under such passionate leaders who continuously motivate me to be a better person. My sincerest gratitude to Geoff Pietersz and James McFadyen for your patient guidance, expertise and motivation.
    [Show full text]